Every material Form 8-K Zevia PBC has filed with the SEC since August 05, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Zevia reported third quarter 2026 results on November 4, 2026, with net sales up 18.4% to $48.3 million and net loss narrowing to $2.2 million, or $0.03 per share. The company raised its 2026 net sales guidance to $177 million to $179 million and its Adjusted EBITDA outlook to between breakeven and a loss of $0.4 million, and it disclosed a $20 million growth equity agreement with GP Investments.
Net sales rose 18.4% year over year to $48.3 million from $40.8 million, with volume up 14.4%.
Net loss was $2.2 million, or $0.03 per share, compared with a net loss of $2.8 million in the third quarter of 2025.
2026 net sales guidance now $177 million to $179 million; fourth quarter net sales expected at $37.5 million to $39.5 million.
On October 22, 2026, Zevia agreed to issue convertible preferred stock to a fund managed by GP Investments Ltd. for $20 million of growth equity.
Zevia agreed on October 22, 2026 to sell up to $20 million of Series A Senior Convertible Preferred Stock to Bubble Holdings, an affiliate of GP Investments; $15 million closed that day and the remaining $5 million depends on 2026 net sales and Adjusted EBITDA targets. The company also said preliminary third quarter 2026 net sales are about $48 million, above its prior $44 million to $46 million guidance, and Adjusted EBITDA is expected to be between negative $900 thousand and negative $1.0 million, better than its prior negative $3.0 million to negative $3.5 million range, though the convertible preferred is dilutive to common shareholders.
$15 million of Series A Preferred Stock issued October 22, 2026; remaining $5 million deferred closing requires 2026 net sales of at least $172.5 million and Adjusted EBITDA of no less than negative $3.0 million
Preferred accrues a 6.00% dividend and converts initially at $1.448 per share, with conversion capped at 14,428,844 shares
Purchaser gets the right to designate one board director; board size increased to eight members
Preliminary Q3 2026 net sales about $48 million vs. prior guidance of $44 million to $46 million; full results due November 4, 2026
Zevia reported second-quarter 2026 net sales of $45.0 million, up 1.1% from a year earlier, driven by pricing actions partly offset by a 3.7% volume decline. The net loss widened to $2.9 million, or $0.04 per share, from $0.7 million, or $0.01 per share, mainly because of higher equity-based compensation. The company kept its full-year 2026 outlook unchanged, which matters to shareholders because it signals no change in expected sales or adjusted EBITDA targets.
Net sales rose 1.1% to $45.0 million from $44.5 million, with volume down 3.7%
Net loss was $2.9 million, or $0.04 per share, versus $0.7 million, or $0.01 per share, a year earlier; equity-based compensation was $2.1 million
Adjusted EBITDA was $0.5 million, up from $0.2 million; restructuring expenses were $1.0 million
Full-year 2026 outlook held: net sales of $170 million to $175 million and adjusted EBITDA loss of $2.0 million to $4.0 million; third-quarter net sales expected at $44.0 million to $46.0 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Zevia PBC filing is on SEC EDGAR ↗. 8-K briefs of other companies →